The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 27, 2021

Filed:

Jun. 18, 2019
Applicant:

Kashiv Biosciences, Llc, Bridgewater, NJ (US);

Inventors:

Siva Ram Kiran Vaka, Piscataway, NJ (US);

Namdev B. Shelke, Somerville, NJ (US);

Dipen Desai, Whippany, NJ (US);

Wantanee Phuapradit, Montville, NJ (US);

Navnit H. Shah, Clifton, NJ (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 31/4425 (2006.01); A61K 9/28 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2866 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2031 (2013.01); A61K 9/284 (2013.01); A61K 9/2886 (2013.01); A61K 31/4425 (2013.01);
Abstract

Extended release pyridostigmine dosage forms, suitable for maintaining stable plasma concentrations with reduced or minimized initial burst release/dose dumping of pyridostigmine, are provided. The dosage forms include matrix tablets, gastroretentive tablets, and pellets, the latter being suitable for dosing in capsules, tablets, and sachets, as well as for sprinkling on foodstuffs. The disclosure also provides methods for improving patient compliance by administering once-a-day extended release pyridostigmine bromide dosage forms that provide a superior controlled drug release.


Find Patent Forward Citations

Loading…